During the past decade, Ausl 3 Di Pistoia - Pistoia (Pt) Oncologia Medica conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ausl 3 Di Pistoia - Pistoia (Pt) Oncologia Medica" are "Colorectal Cancer" (1 trials) and "Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Ausl 3 Di Pistoia - Pistoia (Pt) Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Ausl 3 Di Pistoia - Pistoia (Pt) Oncologia Medica" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "FOLFIRI" (1 trials), "FOLFOXIRI" (1 trials), "bevacizumab" (1 trials), "fluorouracil" (1 trials) and "irinotecan hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ausl 3 Di Pistoia - Pistoia (Pt) Oncologia Medica" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ausl 3 Di Pistoia - Pistoia (Pt) Oncologia Medica". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ausl 3 Di Pistoia - Pistoia (Pt) Oncologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ausl 3 Di Pistoia - Pistoia (Pt) Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".